Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 394

1.

The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice.

Liu Z, Han Y, Li L, Lu H, Meng G, Li X, Shirhan M, Peh MT, Xie L, Zhou S, Wang X, Chen Q, Dai W, Tan CH, Pan S, Moore PK, Ji Y.

Br J Pharmacol. 2013 Aug;169(8):1795-809. doi: 10.1111/bph.12246.

2.

Dysregulation of cystathionine γ-lyase (CSE)/hydrogen sulfide pathway contributes to ox-LDL-induced inflammation in macrophage.

Wang XH, Wang F, You SJ, Cao YJ, Cao LD, Han Q, Liu CF, Hu LF.

Cell Signal. 2013 Nov;25(11):2255-62. doi: 10.1016/j.cellsig.2013.07.010. Epub 2013 Jul 18.

PMID:
23872072
3.

The reciprocal relationship between adiponectin and LOX-1 in the regulation of endothelial dysfunction in ApoE knockout mice.

Chen X, Zhang H, McAfee S, Zhang C.

Am J Physiol Heart Circ Physiol. 2010 Sep;299(3):H605-12. doi: 10.1152/ajpheart.01096.2009. Epub 2010 Jun 25.

4.

[Expressions of atherosclerosis-related genes in aorta in young apoE/LDLR double knockout mice].

Dai XD, Yin M, Jing W, DU HQ, Ye HY, Shang YJ, Zhang L, Zou YY, Qu ZP, Pan J.

Sheng Li Xue Bao. 2008 Feb 25;60(1):43-50. Chinese.

5.

Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice.

Wang Y, Zhao X, Jin H, Wei H, Li W, Bu D, Tang X, Ren Y, Tang C, Du J.

Arterioscler Thromb Vasc Biol. 2009 Feb;29(2):173-9. doi: 10.1161/ATVBAHA.108.179333. Epub 2008 Nov 6.

6.

Inhibitory effects of vinpocetine on the progression of atherosclerosis are mediated by Akt/NF-κB dependent mechanisms in apoE-/- mice.

Zhuang J, Peng W, Li H, Lu Y, Wang K, Fan F, Li S, Xu Y.

PLoS One. 2013 Dec 9;8(12):e82509. doi: 10.1371/journal.pone.0082509. eCollection 2013.

7.

Docosahexaenoic acid attenuates VCAM-1 expression and NF-κB activation in TNF-α-treated human aortic endothelial cells.

Wang TM, Chen CJ, Lee TS, Chao HY, Wu WH, Hsieh SC, Sheu HH, Chiang AN.

J Nutr Biochem. 2011 Feb;22(2):187-94. doi: 10.1016/j.jnutbio.2010.01.007. Epub 2010 Jun 22.

PMID:
20573493
8.

The complex effects of the slow-releasing hydrogen sulfide donor GYY4137 in a model of acute joint inflammation and in human cartilage cells.

Li L, Fox B, Keeble J, Salto-Tellez M, Winyard PG, Wood ME, Moore PK, Whiteman M.

J Cell Mol Med. 2013 Mar;17(3):365-76. doi: 10.1111/jcmm.12016. Epub 2013 Jan 28.

9.

Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells.

Lee WJ, Ou HC, Hsu WC, Chou MM, Tseng JJ, Hsu SL, Tsai KL, Sheu WH.

J Vasc Surg. 2010 Nov;52(5):1290-300. doi: 10.1016/j.jvs.2010.04.085. Epub 2010 Aug 8.

10.

Luteolin protects against vascular inflammation in mice and TNF-alpha-induced monocyte adhesion to endothelial cells via suppressing IΚBα/NF-κB signaling pathway.

Jia Z, Nallasamy P, Liu D, Shah H, Li JZ, Chitrakar R, Si H, McCormick J, Zhu H, Zhen W, Li Y.

J Nutr Biochem. 2015 Mar;26(3):293-302. doi: 10.1016/j.jnutbio.2014.11.008. Epub 2014 Dec 15.

11.

Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-κB activation.

Xu S, Liu Z, Huang Y, Le K, Tang F, Huang H, Ogura S, Little PJ, Shen X, Liu P.

Transl Res. 2012 Aug;160(2):114-24. doi: 10.1016/j.trsl.2012.01.008. Epub 2012 Feb 2.

PMID:
22677363
12.

Role of Ox-LDL/LOX-1/NF-κB signaling pathway in regulation of atherosclerotic plaque growth by testosterone in male rabbits.

Li S, Guo Y, Zhu P, Yang T.

Vascul Pharmacol. 2013 Nov-Dec;59(5-6):131-7. doi: 10.1016/j.vph.2012.09.005. Epub 2012 Sep 27.

PMID:
23022624
13.

Celastrol prevents atherosclerosis via inhibiting LOX-1 and oxidative stress.

Gu L, Bai W, Li S, Zhang Y, Han Y, Gu Y, Meng G, Xie L, Wang J, Xiao Y, Shan L, Zhou S, Wei L, Ferro A, Ji Y.

PLoS One. 2013 Jun 17;8(6):e65477. doi: 10.1371/journal.pone.0065477. Print 2013.

14.

GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat.

Li L, Salto-Tellez M, Tan CH, Whiteman M, Moore PK.

Free Radic Biol Med. 2009 Jul 1;47(1):103-13. doi: 10.1016/j.freeradbiomed.2009.04.014. Epub 2009 Apr 15.

PMID:
19375498
15.

IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.

Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song YH, Titterington J, Delafontaine P.

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2684-90. Epub 2007 Oct 4.

16.

Triacetyl-3-hydroxyphenyladenosine, a derivative of cordycepin, attenuates atherosclerosis in apolipoprotein E-knockout mice.

Zhao Z, Song G, Tian H, Yu Y, Tian X, Liu J, Yao S, Luo T, Qin S.

Exp Biol Med (Maywood). 2012 Nov;237(11):1262-72. doi: 10.1258/ebm.2012.011401.

PMID:
23239437
17.

Salusin-β not salusin-α promotes vascular inflammation in ApoE-deficient mice via the I-κBα/NF-κB pathway.

Zhou CH, Liu L, Liu L, Zhang MX, Guo H, Pan J, Yin XX, Ma TF, Wu YQ.

PLoS One. 2014 Mar 12;9(3):e91468. doi: 10.1371/journal.pone.0091468. eCollection 2014.

18.

Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo.

Akhmedov A, Rozenberg I, Paneni F, Camici GG, Shi Y, Doerries C, Sledzinska A, Mocharla P, Breitenstein A, Lohmann C, Stein S, von Lukowicz T, Kurrer MO, Borén J, Becher B, Tanner FC, Landmesser U, Matter CM, Lüscher TF.

Eur Heart J. 2014 Oct 21;35(40):2839-48. doi: 10.1093/eurheartj/eht532. Epub 2014 Jan 12.

PMID:
24419805
19.

Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice.

Song G, Tian H, Qin S, Sun X, Yao S, Zong C, Luo Y, Liu J, Yu Y, Sang H, Wang X.

Atherosclerosis. 2012 Mar;221(1):55-65. doi: 10.1016/j.atherosclerosis.2011.11.043. Epub 2011 Dec 13.

PMID:
22209213
20.

Supplemental Content

Support Center